Applications for pharmacogenomics in pharmacy practice: A scoping review
Abstract Background Pharmacogenomics (PGx) can provide valuable pharmacokinetic and
pharmacodynamic information for the pharmacist's assessment of drug therapy, especially …
pharmacodynamic information for the pharmacist's assessment of drug therapy, especially …
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
Pharmacogenetics (PGx) is the study and application of how interindividual differences in
our genomes can influence drug responses. By evaluating individuals' genetic variability in …
our genomes can influence drug responses. By evaluating individuals' genetic variability in …
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing
Aims: Identify the attitudes and interests of primary care providers (PCPs) in applying clinical
pharmacogenomics (PGx) test results. Materials & methods: A questionnaire was designed …
pharmacogenomics (PGx) test results. Materials & methods: A questionnaire was designed …
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data
J Lanillos, M Carcajona, P Maietta, S Alvarez… - npj Genomic …, 2022 - nature.com
Exome sequencing is utilized in routine clinical genetic diagnosis. The technical robustness
of repurposing large-scale next-generation sequencing data for pharmacogenetics has …
of repurposing large-scale next-generation sequencing data for pharmacogenetics has …
Clinical importance of potential genetic determinants affecting propofol pharmacokinetics and pharmacodynamics
I Budic, T Jevtovic Stoimenov, D Pavlovic… - Frontiers in …, 2022 - frontiersin.org
Interindividual variability in response to drugs used in anesthesia has long been considered
the rule, not the exception. It is important to mention that in anesthesiology, the variability in …
the rule, not the exception. It is important to mention that in anesthesiology, the variability in …
Pharmacogenetics in psychiatric care, a call for uptake of available applications
CATC Lunenburg, C Gasse - Psychiatry Research, 2020 - Elsevier
In this narrative, we evaluate the role of pharmacogenetics in psychiatry from a pragmatic
clinical perspective and address current barriers of clinical implementation of …
clinical perspective and address current barriers of clinical implementation of …
Current published evidence on barriers and proposed strategies for genetic testing implementation in health care settings: a scoping review
Background The slow uptake of genetic testing in routine clinical practice warrants the
attention of researchers and practitioners to find effective strategies to facilitate …
attention of researchers and practitioners to find effective strategies to facilitate …
Retrospective review of pharmacogenetic testing at an academic children's hospital
TA Roberts, JA Wagner, T Sandritter… - Clinical and …, 2021 - Wiley Online Library
There is limited evidence to support pharmacogenetic (PGx) testing in children. We
conducted a retrospective review of PGx testing among 452 patients at an academic …
conducted a retrospective review of PGx testing among 452 patients at an academic …
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease
AL Elchynski, EJ Cicali, MC Ferrer del Busto… - The …, 2021 - nature.com
We aimed to determine the potential value of panel-based pharmacogenetic (PGx) testing in
patients with chronic pain or gastroesophageal reflux disease (GERD) who underwent …
patients with chronic pain or gastroesophageal reflux disease (GERD) who underwent …
Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized with COVID‐19: A Retrospective Multicenter Study in the United States
JM Stevenson, GC Alexander… - Clinical and …, 2021 - Wiley Online Library
Many academic institutions are collecting blood samples from patients seeking treatment for
coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible …
coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible …